{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:55:06Z","timestamp":1746320106095},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1999,4,1]],"date-time":"1999-04-01T00:00:00Z","timestamp":922924800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1999,4]]},"DOI":"10.1007\/bf03343552","type":"journal-article","created":{"date-parts":[[2014,3,11]],"date-time":"2014-03-11T05:32:48Z","timestamp":1394515968000},"page":"250-256","source":"Crossref","is-referenced-by-count":9,"title":["Outcome of treatment of hyperthyroidism"],"prefix":"10.1007","volume":"22","author":[{"given":"I. M.","family":"Bringmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. L.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Hennemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. J.","family":"Beckett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. D.","family":"Toft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,11]]},"reference":[{"key":"BF03343552_CR1","volume-title":"The thyroid and its diseases","author":"LJ Groot De","year":"1996","unstructured":"De Groot L.J., Larsen P.R., Hennemann G. The thyroid and its diseases. Churchill Livingstone, Edinburg, 1996, 6th edition.","edition":"6th edition"},{"key":"BF03343552_CR2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2796.1994.tb00837.x","volume":"236","author":"TWA Bruin De","year":"1994","unstructured":"De Bruin T.W.A., Croon C.D.L., De Klerk J.M.H., Van Isselt J.W. Standardized radioiodine therapy in Graves\u2019 disease: the persistent effect of thyroid weight and radioiodine uptake on outcome. J. Int. Med. 1994, 236: 507\u2013513.","journal-title":"J. Int. Med."},{"key":"BF03343552_CR3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.me.44.020193.001543","volume":"44","author":"U Feldt-Rasmussen","year":"1993","unstructured":"Feldt-Rasmussen U., Glinoer D., Orgiazzi J. Reassessment of antithyroid drug therapy of Graves\u2019 disease. Annu. Rev. Med. 1993, 44: 323\u2013334.","journal-title":"Annu. Rev. Med."},{"key":"BF03343552_CR4","first-page":"1731","volume":"30","author":"JA Franklyn","year":"1994","unstructured":"Franklyn J.A. The management of hyperthyroidism. New Engl. J. Med. 1994, 30: 1731\u20131738.","journal-title":"New Engl. J. Med."},{"key":"BF03343552_CR5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2265.1991.tb03523.x","volume":"35","author":"JJ Farrar","year":"1991","unstructured":"Farrar J.J., Toft A. Iodine-131 treatment of hyperthyroidism: current issues. Clin. Endocrinol. 1991, 35: 207\u2013212.","journal-title":"Clin. Endocrinol."},{"key":"BF03343552_CR6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2265.1992.tb02330.x","volume":"37","author":"AP Weetman","year":"1992","unstructured":"Weetman A.P. How anti thyroid drugs work in Graves\u2019 disease. Clin. Endocrinol. 1992, 37: 317\u2013318.","journal-title":"Clin. Endocrinol"},{"key":"BF03343552_CR7","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(05)65600-0","volume":"348","author":"LE Braverman","year":"1996","unstructured":"Braverman L.E. Is there one succesful antithyroid regimen for Graves\u2019 disease? Lancet 1996, 348: 697\u2013698.","journal-title":"Lancet"},{"issue":"11\u201312","key":"BF03343552_CR8","first-page":"415","volume":"35","author":"RM Jenkins","year":"1981","unstructured":"Jenkins R.M., Evans D.M.D. Carbimazole hypersensitivity and liver damage. Br. J. Clin. Practice 1981, 35 (11\u201312): 415\u2013417.","journal-title":"Br. J. Clin. Practice"},{"key":"BF03343552_CR9","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2362.1995.tb01547.x","volume":"25","author":"H Peters","year":"1995","unstructured":"Peters H., Fisher C., Bogner U., Reiners C., Schleusener H. Radioiodine therapy of Graves\u2019 hyperthyroidism: standard vs calculated 131I iodine activity. Results from a prospective, randomized, multicenter study. Eur. J. Clin. Invest. 1995, 25: 186\u2013193.","journal-title":"Eur. J. Clin. Invest."},{"issue":"7","key":"BF03343552_CR10","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1056\/NEJM198408163110702","volume":"311","author":"V Sridama","year":"1984","unstructured":"Sridama V., McCormick M., Kaplan E.L., Fauchet R., De Groot L.J. Long-term follow-up study of compensated low-dose 131I therapy for Graves\u2019 disease. New Engl. J. Med. 1984, 311 (7) 426\u2013432.","journal-title":"New Engl. J. Med."},{"key":"BF03343552_CR11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0002-9343(99)80137-5","volume":"99","author":"HL Uy","year":"1995","unstructured":"Uy H.L., Reasner C.A., Samuels M.H. Pattern of recovery of the hypothalamic-pituitary-thyroid axis following radioactive iodine therapy in patients with Graves\u2019 disease. Am. J. Med. 1995, 99: 173\u2013179.","journal-title":"Am. J. Med."},{"key":"BF03343552_CR12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1365-2265.1997.d01-1747.x","volume":"46","author":"A Toft","year":"1997","unstructured":"Toft A. Transient hypothyroidism. Clin. Endocr. 1997, 46: 7\u20138.","journal-title":"Clin. Endocr."},{"key":"BF03343552_CR13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1365-2362.1996.98243.x","volume":"26","author":"H Peters","year":"1996","unstructured":"Peters H., Fisher C., Bogner U., Reiners C., Schleusener H. Reduction in thyroid volume after radioiodine therapy of Graves\u2019 hyperthyroidism: results of a prospective, randomized, multicenter study. Eur. J. Clin. Invest. 1996, 26: 59\u201363.","journal-title":"Eur. J. Clin. Invest."},{"key":"BF03343552_CR14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2265.1995.tb02030.x","volume":"43","author":"G Benker","year":"1995","unstructured":"Benker G., Vitti P., Kahaly G., Raue F., Tegler L., Hirche H., Reinwein D., the European Multicenter Study Group. Response to methimazole in Graves\u2019 disease. Clin. Endocrinol. (Oxf.) 1995, 43: 257\u2013263.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"5","key":"BF03343552_CR15","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1532-5415.1994.tb04973.x","volume":"42","author":"T Yamada","year":"1994","unstructured":"Yamada T., Aizawa T., Koizumi Y., Komiya I., Ichikawa K., Hashizume K. Age-related therapeutic response to antithyroid drug in patients with hyperthyroid Graves\u2019 disease. J. Am. Geri. Soc. 42 (5) 1994, 513\u2013516.","journal-title":"J. Am. Geri. Soc."},{"key":"BF03343552_CR16","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1365-2265.1996.00800.x","volume":"45","author":"SR Page","year":"1996","unstructured":"Page S.R., Sheard C.E., Herbert M., Hopton M., Jeffcoate W.J. A comparison of 20 or 40 mg per day of carbimazole in the initial treatment of hyperthyroidism. Clin. Endocrinol. (Oxf.) 1996, 45: 511\u2013515.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03343552_CR17","first-page":"1516","volume":"76","author":"D Reinwein","year":"1993","unstructured":"Reinwein D., Benker G., Lazarus J.H., Alexander W.D., the European Multicenter Study Group on Antithyroid Drug Treatment. Prospective randomized trial of antithyroid drug dose in Graves\u2019 disease therapy. J. Clin. Endocrinol. Metab. 1993, 76: 1516\u20131521.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343552_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2265.1997.d01-1737.x","volume":"46","author":"Y Aizawa","year":"1996","unstructured":"Aizawa Y., Yoshida K., Kaise N., Fukazawa H., Kiso Y., Sayama N., Hori H., Abe K. The development of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves\u2019 disease: prevalence, mechanism and prognosis. Clin. Endocrinol. (Oxf.) 1996, 46: 1\u20135.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03343552_CR19","first-page":"1539","volume":"36","author":"N Gomez","year":"1995","unstructured":"Gomez N., Gomez J.M., Orti A., Gavalda L., Villabona C., Leyes P., Soler S. Transient hypothyroidism after iodine-131 therapy for Graves\u2019 disease. J. Nucl. Med. 1995, 36: 1539\u20131542.","journal-title":"J. Nucl. Med."},{"key":"BF03343552_CR20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(97)80050-5","volume":"349","author":"RS Lindsay","year":"1997","unstructured":"Lindsay R.S., Toft A.D. Hypothyroidism. Lancet 1997, 349: 413\u2013417.","journal-title":"Lancet"},{"key":"BF03343552_CR21","first-page":"175","volume":"88","author":"JA Franklyn","year":"1995","unstructured":"Franklyn J.A., Daykin J., Holder R., Sheppard M.C. Radioiodine therapy compared in patients with toxic nodular or Graves\u2019 hyperthyroidism. Q. J. Med. 1995, 88: 175\u2013180.","journal-title":"Q. J. Med."},{"key":"BF03343552_CR22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2796.1996.441788000.x","volume":"239","author":"G Berg","year":"1996","unstructured":"Berg G., Michanek A., Holmberg E., Nystrom E. Clinical outcome of radioiodine treatment of hyperthyroidism: a follow up study. J. Int. Med. 1996, 239: 165\u2013171.","journal-title":"J. Int. Med."},{"key":"BF03343552_CR23","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1210\/jcem-50-2-226","volume":"50","author":"JSA Sawers","year":"1980","unstructured":"Sawers J.S.A., Toft A.D., Irvine W.J., Brown N.S., Seth J. Transient hypothyroidism after iodine-131 treatment of thyrotoxicosis. J. Clin. Endocrinol. Metab. 1980, 50: 226\u2013229;.","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03343552.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03343552\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03343552","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T21:44:44Z","timestamp":1558561484000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03343552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1999,4]]}},"alternative-id":["BF03343552"],"URL":"https:\/\/doi.org\/10.1007\/bf03343552","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,4]]}}}